Molecular Diagnostics Quarterly Datastream

    Published: May 5, 2022 | Price: $10,000.00

    NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests Report, World Molecular Diagnostics Report or Molecular Point-of-Care (POC) report.  All in any edition.  This is because this is a quarterly update to markets covered in these reports.     The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel...
    Cell Therapy and Gene Therapy Markets, 2021-2031

    Published: February 18, 2022 | Price: $6,000.00 – $12,000.00

    Authoritative Information on Cell and Gene Therapy Markets Cell Therapy And Gene Therapy Markets, 2021-2031 from Kalorama Information presents the market in segments that provide an overview of disease epidemiology, market estimates and forecasts, and competitive summary of leading providers: Cell and Gene Therapy Market Summary by Product Segment, 2021-2031 ($ millions) (Dermatological, Cardiovascular – Blood, Oncology, Ophthalmic, Musculoskeletal, Other conditions, Total Market) Cell and Gene Therapy Market Summary by Method, 2021-2031 ($ millions) (Cell Therapy, Gene Therapy, Total Market) Cell...
    Cell and Gene Therapy Business Outlook

    Published: January 1, 2022 | Price:

    How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions.  It can be a daunting task to keep up.  Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore.  Now from Science and Medicine...
    World Market for Cancer Diagnostics

    Published: November 22, 2021 | Price: $9,000.00 – $12,000.00

    Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence.  The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity assessment. Segment markets for cancer testing are comprehensively covered in Kalorama Information’s World Market for Cancer Diagnostics. ...
    Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

    Published: June 17, 2020 | Price: $6,000.00 – $12,000.00

    Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes.   Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...
    Cell Therapy and Gene Therapy Markets

    Published: April 27, 2020 | Price: $5,500.00 – $11,000.00

    What is the Size of the Cell and Gene Therapy Market? According to the latest report on the cell and gene therapy market from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3,866 million And most of the market is for the treatment of cancer. Dermatological, Cardiovascular – Blood, Oncology, Ophthalmic, Musculoskeletal and other conditions. With the COVID-19 crisis, there are some efforts to adapt this promising technology to the treatment and...